Chartwell Investment Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-7,086
Closed -$691K 426
2022
Q2
$691K Buy
7,086
+106
+2% +$10.3K 0.03% 379
2022
Q1
$654K Buy
6,980
+408
+6% +$38.2K 0.02% 396
2021
Q4
$560K Hold
6,572
0.02% 406
2021
Q3
$630K Sell
6,572
-15,271
-70% -$1.46M 0.02% 403
2021
Q2
$2.13M Sell
21,843
-14
-0.1% -$1.36K 0.06% 287
2021
Q1
$2.13M Sell
21,857
-2,175
-9% -$211K 0.06% 276
2020
Q4
$2.3M Buy
24,032
+214
+0.9% +$20.5K 0.07% 266
2020
Q3
$2.29M Buy
23,818
+4,918
+26% +$473K 0.08% 255
2020
Q2
$2.31M Buy
18,900
+12,782
+209% +$1.56M 0.09% 254
2020
Q1
$530K Sell
6,118
-300
-5% -$26K 0.02% 364
2019
Q4
$690K Hold
6,418
0.02% 374
2019
Q3
$578K Sell
6,418
-182
-3% -$16.4K 0.02% 386
2019
Q2
$557K Sell
6,600
-1,507
-19% -$127K 0.02% 394
2019
Q1
$714K Buy
8,107
+413
+5% +$36.4K 0.02% 400
2018
Q4
$549K Sell
7,694
-362
-4% -$25.8K 0.02% 424
2018
Q3
$990K Sell
8,056
-33,122
-80% -$4.07M 0.03% 442
2018
Q2
$4.05M Sell
41,178
-20,081
-33% -$1.97M 0.12% 230
2018
Q1
$5.08M Sell
61,259
-1,023
-2% -$84.8K 0.17% 184
2017
Q4
$4.83M Sell
62,282
-11,146
-15% -$865K 0.16% 203
2017
Q3
$4.5M Buy
73,428
+3,532
+5% +$216K 0.15% 204
2017
Q2
$3.22M Buy
69,896
+3,992
+6% +$184K 0.12% 231
2017
Q1
$2.85M Sell
65,904
-80,108
-55% -$3.47M 0.1% 240
2016
Q4
$5.65M Buy
146,012
+24,057
+20% +$931K 0.19% 170
2016
Q3
$6.18M Buy
+121,955
New +$6.18M 0.11% 225